PDB Short entry for 5CWZ HEADER TRANSFERASE/TRANSFERASE INHIBITOR 28-JUL-15 5CWZ TITLE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- TITLE 2 INTERACTING PROTEIN KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRAF2 AND NCK-INTERACTING PROTEIN KINASE; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: UNP RESIDUES 11-314; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNIK, KIAA0551; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.OHBAYASHI,M.KUKIMOTO-NIINO,T.YAMADA,M.SHIROUZU REVDAT 3 19-FEB-20 5CWZ 1 REMARK REVDAT 2 07-SEP-16 5CWZ 1 JRNL REVDAT 1 27-JUL-16 5CWZ 0 JRNL AUTH M.MASUDA,Y.UNO,N.OHBAYASHI,H.OHATA,A.MIMATA, JRNL AUTH 2 M.KUKIMOTO-NIINO,H.MORIYAMA,S.KASHIMOTO,T.INOUE,N.GOTO, JRNL AUTH 3 K.OKAMOTO,M.SHIROUZU,M.SAWA,T.YAMADA JRNL TITL TNIK INHIBITION ABROGATES COLORECTAL CANCER STEMNESS JRNL REF NAT COMMUN V. 7 12586 2016 JRNL REFN ESSN 2041-1723 JRNL PMID 27562646 JRNL DOI 10.1038/NCOMMS12586 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.59 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 22686 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 1161 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.5929 - 5.7972 1.00 2866 158 0.1979 0.2501 REMARK 3 2 5.7972 - 4.6025 1.00 2708 146 0.2010 0.2533 REMARK 3 3 4.6025 - 4.0211 1.00 2716 138 0.1764 0.2628 REMARK 3 4 4.0211 - 3.6536 1.00 2634 169 0.2079 0.2962 REMARK 3 5 3.6536 - 3.3918 1.00 2662 134 0.2216 0.3201 REMARK 3 6 3.3918 - 3.1918 1.00 2624 148 0.2389 0.3227 REMARK 3 7 3.1918 - 3.0320 1.00 2676 123 0.2526 0.3147 REMARK 3 8 3.0320 - 2.9000 1.00 2639 145 0.2723 0.3651 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.420 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.490 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 6872 REMARK 3 ANGLE : 0.791 9274 REMARK 3 CHIRALITY : 0.030 1008 REMARK 3 PLANARITY : 0.004 1195 REMARK 3 DIHEDRAL : 12.853 2607 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SF FILE CONTAINS FRIEDEL PAIRS UNDER REMARK 3 I/F_MINUS AND I/F_PLUS COLUMNS. REMARK 4 REMARK 4 5CWZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-AUG-15. REMARK 100 THE DEPOSITION ID IS D_1000211994. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22760 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 48.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : 0.69200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2X7F REMARK 200 REMARK 200 REMARK: THE ENTRY CONTAINS FRIEDEL PAIRS IN F_PLUS/MINUS COLUMNS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE, 0.1M BIS-TRIS REMARK 280 (6.2), 35% PEG3350, 9% ETHYLENE GLYCOL, PH 6.2, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 61.94800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.22500 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 61.94800 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 79.22500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 GLY A 9 REMARK 465 ALA A 10 REMARK 465 THR A 35 REMARK 465 TYR A 36 REMARK 465 SER A 175 REMARK 465 ALA A 176 REMARK 465 GLN A 177 REMARK 465 LEU A 178 REMARK 465 ASP A 179 REMARK 465 ARG A 180 REMARK 465 THR A 181 REMARK 465 VAL A 182 REMARK 465 GLY A 183 REMARK 465 ARG A 184 REMARK 465 ARG A 185 REMARK 465 ARG A 308 REMARK 465 THR A 309 REMARK 465 LYS A 310 REMARK 465 LYS A 311 REMARK 465 LYS A 312 REMARK 465 ARG A 313 REMARK 465 GLY A 314 REMARK 465 GLY B 7 REMARK 465 SER B 8 REMARK 465 GLY B 9 REMARK 465 ALA B 10 REMARK 465 THR B 35 REMARK 465 TYR B 36 REMARK 465 SER B 175 REMARK 465 ALA B 176 REMARK 465 GLN B 177 REMARK 465 LEU B 178 REMARK 465 ASP B 179 REMARK 465 ARG B 180 REMARK 465 THR B 181 REMARK 465 VAL B 182 REMARK 465 GLY B 183 REMARK 465 ARG B 184 REMARK 465 ARG B 185 REMARK 465 ARG B 308 REMARK 465 THR B 309 REMARK 465 LYS B 310 REMARK 465 LYS B 311 REMARK 465 LYS B 312 REMARK 465 ARG B 313 REMARK 465 GLY B 314 REMARK 465 GLY C 7 REMARK 465 SER C 8 REMARK 465 GLY C 9 REMARK 465 ALA C 10 REMARK 465 ASP C 11 REMARK 465 GLU C 12 REMARK 465 ILE C 13 REMARK 465 ASP C 14 REMARK 465 THR C 35 REMARK 465 TYR C 36 REMARK 465 GLY C 60 REMARK 465 ASP C 61 REMARK 465 GLU C 62 REMARK 465 GLU C 63 REMARK 465 GLU C 64 REMARK 465 GLU C 65 REMARK 465 SER C 175 REMARK 465 ALA C 176 REMARK 465 GLN C 177 REMARK 465 LEU C 178 REMARK 465 ASP C 179 REMARK 465 ARG C 180 REMARK 465 THR C 181 REMARK 465 VAL C 182 REMARK 465 GLY C 183 REMARK 465 ARG C 184 REMARK 465 ARG C 185 REMARK 465 ASN C 186 REMARK 465 THR C 187 REMARK 465 PHE C 188 REMARK 465 ILE C 189 REMARK 465 THR C 309 REMARK 465 LYS C 310 REMARK 465 LYS C 311 REMARK 465 LYS C 312 REMARK 465 ARG C 313 REMARK 465 GLY C 314 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU C 73 OG SER C 77 2.11 REMARK 500 OH TYR A 40 OD1 ASP B 98 2.13 REMARK 500 O LEU A 73 OG SER A 77 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 33 -155.30 -132.57 REMARK 500 GLU A 62 1.44 -63.85 REMARK 500 ARG A 152 -13.57 81.58 REMARK 500 ASP A 153 55.34 -147.37 REMARK 500 THR A 162 -169.50 -78.96 REMARK 500 THR B 47 -36.58 -130.62 REMARK 500 LYS B 121 105.57 -58.76 REMARK 500 ASP B 153 56.00 -173.75 REMARK 500 CYS B 202 -120.43 -140.04 REMARK 500 ASP B 235 42.89 -79.04 REMARK 500 LYS B 254 -76.20 -68.11 REMARK 500 GLN B 292 68.91 -166.43 REMARK 500 ALA C 22 105.69 -58.98 REMARK 500 ASP C 153 53.34 -167.71 REMARK 500 CYS C 202 -137.82 -104.02 REMARK 500 PRO C 246 20.90 -79.88 REMARK 500 ASP C 291 72.30 -107.58 REMARK 500 ASN C 294 -169.22 -169.15 REMARK 500 GLN C 297 -61.05 -92.73 REMARK 500 REMARK 500 REMARK: NULL DBREF 5CWZ A 11 314 UNP Q9UKE5 TNIK_HUMAN 11 314 DBREF 5CWZ B 11 314 UNP Q9UKE5 TNIK_HUMAN 11 314 DBREF 5CWZ C 11 314 UNP Q9UKE5 TNIK_HUMAN 11 314 SEQADV 5CWZ GLY A 7 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ SER A 8 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ GLY A 9 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ ALA A 10 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ GLY B 7 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ SER B 8 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ GLY B 9 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ ALA B 10 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ GLY C 7 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ SER C 8 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ GLY C 9 UNP Q9UKE5 EXPRESSION TAG SEQADV 5CWZ ALA C 10 UNP Q9UKE5 EXPRESSION TAG SEQRES 1 A 308 GLY SER GLY ALA ASP GLU ILE ASP LEU SER ALA LEU ARG SEQRES 2 A 308 ASP PRO ALA GLY ILE PHE GLU LEU VAL GLU LEU VAL GLY SEQRES 3 A 308 ASN GLY THR TYR GLY GLN VAL TYR LYS GLY ARG HIS VAL SEQRES 4 A 308 LYS THR GLY GLN LEU ALA ALA ILE LYS VAL MET ASP VAL SEQRES 5 A 308 THR GLY ASP GLU GLU GLU GLU ILE LYS GLN GLU ILE ASN SEQRES 6 A 308 MET LEU LYS LYS TYR SER HIS HIS ARG ASN ILE ALA THR SEQRES 7 A 308 TYR TYR GLY ALA PHE ILE LYS LYS ASN PRO PRO GLY MET SEQRES 8 A 308 ASP ASP GLN LEU TRP LEU VAL MET GLU PHE CYS GLY ALA SEQRES 9 A 308 GLY SER VAL THR ASP LEU ILE LYS ASN THR LYS GLY ASN SEQRES 10 A 308 THR LEU LYS GLU GLU TRP ILE ALA TYR ILE CYS ARG GLU SEQRES 11 A 308 ILE LEU ARG GLY LEU SER HIS LEU HIS GLN HIS LYS VAL SEQRES 12 A 308 ILE HIS ARG ASP ILE LYS GLY GLN ASN VAL LEU LEU THR SEQRES 13 A 308 GLU ASN ALA GLU VAL LYS LEU VAL ASP PHE GLY VAL SER SEQRES 14 A 308 ALA GLN LEU ASP ARG THR VAL GLY ARG ARG ASN THR PHE SEQRES 15 A 308 ILE GLY THR PRO TYR TRP MET ALA PRO GLU VAL ILE ALA SEQRES 16 A 308 CYS ASP GLU ASN PRO ASP ALA THR TYR ASP PHE LYS SER SEQRES 17 A 308 ASP LEU TRP SER LEU GLY ILE THR ALA ILE GLU MET ALA SEQRES 18 A 308 GLU GLY ALA PRO PRO LEU CYS ASP MET HIS PRO MET ARG SEQRES 19 A 308 ALA LEU PHE LEU ILE PRO ARG ASN PRO ALA PRO ARG LEU SEQRES 20 A 308 LYS SER LYS LYS TRP SER LYS LYS PHE GLN SER PHE ILE SEQRES 21 A 308 GLU SER CYS LEU VAL LYS ASN HIS SER GLN ARG PRO ALA SEQRES 22 A 308 THR GLU GLN LEU MET LYS HIS PRO PHE ILE ARG ASP GLN SEQRES 23 A 308 PRO ASN GLU ARG GLN VAL ARG ILE GLN LEU LYS ASP HIS SEQRES 24 A 308 ILE ASP ARG THR LYS LYS LYS ARG GLY SEQRES 1 B 308 GLY SER GLY ALA ASP GLU ILE ASP LEU SER ALA LEU ARG SEQRES 2 B 308 ASP PRO ALA GLY ILE PHE GLU LEU VAL GLU LEU VAL GLY SEQRES 3 B 308 ASN GLY THR TYR GLY GLN VAL TYR LYS GLY ARG HIS VAL SEQRES 4 B 308 LYS THR GLY GLN LEU ALA ALA ILE LYS VAL MET ASP VAL SEQRES 5 B 308 THR GLY ASP GLU GLU GLU GLU ILE LYS GLN GLU ILE ASN SEQRES 6 B 308 MET LEU LYS LYS TYR SER HIS HIS ARG ASN ILE ALA THR SEQRES 7 B 308 TYR TYR GLY ALA PHE ILE LYS LYS ASN PRO PRO GLY MET SEQRES 8 B 308 ASP ASP GLN LEU TRP LEU VAL MET GLU PHE CYS GLY ALA SEQRES 9 B 308 GLY SER VAL THR ASP LEU ILE LYS ASN THR LYS GLY ASN SEQRES 10 B 308 THR LEU LYS GLU GLU TRP ILE ALA TYR ILE CYS ARG GLU SEQRES 11 B 308 ILE LEU ARG GLY LEU SER HIS LEU HIS GLN HIS LYS VAL SEQRES 12 B 308 ILE HIS ARG ASP ILE LYS GLY GLN ASN VAL LEU LEU THR SEQRES 13 B 308 GLU ASN ALA GLU VAL LYS LEU VAL ASP PHE GLY VAL SER SEQRES 14 B 308 ALA GLN LEU ASP ARG THR VAL GLY ARG ARG ASN THR PHE SEQRES 15 B 308 ILE GLY THR PRO TYR TRP MET ALA PRO GLU VAL ILE ALA SEQRES 16 B 308 CYS ASP GLU ASN PRO ASP ALA THR TYR ASP PHE LYS SER SEQRES 17 B 308 ASP LEU TRP SER LEU GLY ILE THR ALA ILE GLU MET ALA SEQRES 18 B 308 GLU GLY ALA PRO PRO LEU CYS ASP MET HIS PRO MET ARG SEQRES 19 B 308 ALA LEU PHE LEU ILE PRO ARG ASN PRO ALA PRO ARG LEU SEQRES 20 B 308 LYS SER LYS LYS TRP SER LYS LYS PHE GLN SER PHE ILE SEQRES 21 B 308 GLU SER CYS LEU VAL LYS ASN HIS SER GLN ARG PRO ALA SEQRES 22 B 308 THR GLU GLN LEU MET LYS HIS PRO PHE ILE ARG ASP GLN SEQRES 23 B 308 PRO ASN GLU ARG GLN VAL ARG ILE GLN LEU LYS ASP HIS SEQRES 24 B 308 ILE ASP ARG THR LYS LYS LYS ARG GLY SEQRES 1 C 308 GLY SER GLY ALA ASP GLU ILE ASP LEU SER ALA LEU ARG SEQRES 2 C 308 ASP PRO ALA GLY ILE PHE GLU LEU VAL GLU LEU VAL GLY SEQRES 3 C 308 ASN GLY THR TYR GLY GLN VAL TYR LYS GLY ARG HIS VAL SEQRES 4 C 308 LYS THR GLY GLN LEU ALA ALA ILE LYS VAL MET ASP VAL SEQRES 5 C 308 THR GLY ASP GLU GLU GLU GLU ILE LYS GLN GLU ILE ASN SEQRES 6 C 308 MET LEU LYS LYS TYR SER HIS HIS ARG ASN ILE ALA THR SEQRES 7 C 308 TYR TYR GLY ALA PHE ILE LYS LYS ASN PRO PRO GLY MET SEQRES 8 C 308 ASP ASP GLN LEU TRP LEU VAL MET GLU PHE CYS GLY ALA SEQRES 9 C 308 GLY SER VAL THR ASP LEU ILE LYS ASN THR LYS GLY ASN SEQRES 10 C 308 THR LEU LYS GLU GLU TRP ILE ALA TYR ILE CYS ARG GLU SEQRES 11 C 308 ILE LEU ARG GLY LEU SER HIS LEU HIS GLN HIS LYS VAL SEQRES 12 C 308 ILE HIS ARG ASP ILE LYS GLY GLN ASN VAL LEU LEU THR SEQRES 13 C 308 GLU ASN ALA GLU VAL LYS LEU VAL ASP PHE GLY VAL SER SEQRES 14 C 308 ALA GLN LEU ASP ARG THR VAL GLY ARG ARG ASN THR PHE SEQRES 15 C 308 ILE GLY THR PRO TYR TRP MET ALA PRO GLU VAL ILE ALA SEQRES 16 C 308 CYS ASP GLU ASN PRO ASP ALA THR TYR ASP PHE LYS SER SEQRES 17 C 308 ASP LEU TRP SER LEU GLY ILE THR ALA ILE GLU MET ALA SEQRES 18 C 308 GLU GLY ALA PRO PRO LEU CYS ASP MET HIS PRO MET ARG SEQRES 19 C 308 ALA LEU PHE LEU ILE PRO ARG ASN PRO ALA PRO ARG LEU SEQRES 20 C 308 LYS SER LYS LYS TRP SER LYS LYS PHE GLN SER PHE ILE SEQRES 21 C 308 GLU SER CYS LEU VAL LYS ASN HIS SER GLN ARG PRO ALA SEQRES 22 C 308 THR GLU GLN LEU MET LYS HIS PRO PHE ILE ARG ASP GLN SEQRES 23 C 308 PRO ASN GLU ARG GLN VAL ARG ILE GLN LEU LYS ASP HIS SEQRES 24 C 308 ILE ASP ARG THR LYS LYS LYS ARG GLY FORMUL 4 HOH *2(H2 O) HELIX 1 AA1 ASP A 14 LEU A 18 5 5 HELIX 2 AA2 GLU A 62 SER A 77 1 16 HELIX 3 AA3 SER A 112 THR A 120 1 9 HELIX 4 AA4 LYS A 126 HIS A 147 1 22 HELIX 5 AA5 ASP A 211 GLY A 229 1 19 HELIX 6 AA6 HIS A 237 ASN A 248 1 12 HELIX 7 AA7 SER A 259 LEU A 270 1 12 HELIX 8 AA8 ASN A 273 ARG A 277 5 5 HELIX 9 AA9 ALA A 279 LYS A 285 1 7 HELIX 10 AB1 HIS A 286 ASP A 291 1 6 HELIX 11 AB2 ASN A 294 ILE A 306 1 13 HELIX 12 AB3 THR B 59 ASP B 61 5 3 HELIX 13 AB4 GLU B 62 SER B 77 1 16 HELIX 14 AB5 VAL B 113 ASN B 119 1 7 HELIX 15 AB6 LYS B 126 HIS B 147 1 22 HELIX 16 AB7 ASP B 211 GLY B 229 1 19 HELIX 17 AB8 HIS B 237 ILE B 245 1 9 HELIX 18 AB9 SER B 259 LEU B 270 1 12 HELIX 19 AC1 ASN B 273 ARG B 277 5 5 HELIX 20 AC2 ALA B 279 LYS B 285 1 7 HELIX 21 AC3 HIS B 286 ASP B 291 1 6 HELIX 22 AC4 ASN B 294 HIS B 305 1 12 HELIX 23 AC5 LYS C 67 SER C 77 1 11 HELIX 24 AC6 VAL C 113 ASN C 119 1 7 HELIX 25 AC7 LYS C 126 HIS C 147 1 22 HELIX 26 AC8 ASP C 211 GLY C 229 1 19 HELIX 27 AC9 HIS C 237 ILE C 245 1 9 HELIX 28 AD1 SER C 259 LEU C 270 1 12 HELIX 29 AD2 ALA C 279 LYS C 285 1 7 HELIX 30 AD3 HIS C 286 ASP C 291 1 6 HELIX 31 AD4 GLN C 297 ILE C 306 1 10 SHEET 1 AA1 5 PHE A 25 GLY A 32 0 SHEET 2 AA1 5 GLN A 38 HIS A 44 -1 O LYS A 41 N GLU A 29 SHEET 3 AA1 5 LEU A 50 VAL A 58 -1 O ILE A 53 N TYR A 40 SHEET 4 AA1 5 ASP A 99 MET A 105 -1 O MET A 105 N ALA A 52 SHEET 5 AA1 5 TYR A 85 LYS A 91 -1 N PHE A 89 O TRP A 102 SHEET 1 AA2 2 VAL A 159 LEU A 161 0 SHEET 2 AA2 2 VAL A 167 LEU A 169 -1 O LYS A 168 N LEU A 160 SHEET 1 AA3 5 PHE B 25 GLY B 32 0 SHEET 2 AA3 5 GLN B 38 HIS B 44 -1 O LYS B 41 N GLU B 29 SHEET 3 AA3 5 LEU B 50 VAL B 58 -1 O ILE B 53 N TYR B 40 SHEET 4 AA3 5 ASP B 99 MET B 105 -1 O LEU B 101 N MET B 56 SHEET 5 AA3 5 TYR B 85 LYS B 91 -1 N PHE B 89 O TRP B 102 SHEET 1 AA4 3 GLY B 111 SER B 112 0 SHEET 2 AA4 3 VAL B 159 LEU B 161 -1 O LEU B 161 N GLY B 111 SHEET 3 AA4 3 VAL B 167 LEU B 169 -1 O LYS B 168 N LEU B 160 SHEET 1 AA5 5 PHE C 25 GLY C 32 0 SHEET 2 AA5 5 GLN C 38 HIS C 44 -1 O LYS C 41 N VAL C 28 SHEET 3 AA5 5 LEU C 50 MET C 56 -1 O ILE C 53 N TYR C 40 SHEET 4 AA5 5 GLN C 100 MET C 105 -1 O LEU C 103 N LYS C 54 SHEET 5 AA5 5 TYR C 85 LYS C 91 -1 N PHE C 89 O TRP C 102 SHEET 1 AA6 3 GLY C 111 SER C 112 0 SHEET 2 AA6 3 VAL C 159 LEU C 161 -1 O LEU C 161 N GLY C 111 SHEET 3 AA6 3 VAL C 167 LEU C 169 -1 O LYS C 168 N LEU C 160 CISPEP 1 ASP C 307 ARG C 308 0 1.21 CRYST1 50.215 123.896 158.450 90.00 90.00 90.00 P 2 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019914 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008071 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006311 0.00000